News from Takeda A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 23, 2016, 12:33 ET Takeda Presents Analyses From Vedolizumab Data in Ulcerative Colitis at 2016 Digestive Disease Week (DDW) Annual Meeting

Takeda Pharmaceutical Company Limited [TSE: 4502], ("Takeda") today announced the oral presentations of two data analyses: one evaluating the...


May 16, 2016, 16:01 ET Takeda and Lundbeck Present Vortioxetine Data at the American Psychiatric Association (APA) 2016 Annual Meeting

 Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4502) and Lundbeck today...


May 02, 2016, 15:32 ET Brintellix (vortioxetine) Renamed Trintellix (vortioxetine) in U.S. to Avoid Name Confusion

 Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE: 4502) (collectively "Takeda"),...


Apr 28, 2016, 13:00 ET Takeda Expands Its Help At Hand Patient Assistance Program in U.S.; Reaches Even More Eligible Patients in the U.S.

Takeda today announced its U.S. Business Unit will expand its patient assistance program to make its prescription drugs available to more eligible...


Mar 31, 2016, 10:51 ET Takeda Launches Multi-Year Research Partnership with Leading Inflammatory Bowel Disease Institutions

 Takeda Pharmaceuticals U.S.A., Inc. ("Takeda"), today announced a multi-year research partnership with two world leading academic centers with...


Mar 28, 2016, 20:02 ET Takeda and Lundbeck Receive Complete Response Letter for Brintellix® (vortioxetine) sNDA

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug...


Mar 15, 2016, 07:05 ET Takeda Pharmaceuticals U.S.A., Inc. Announces Plans to Transform Business, Enhancing Value for Patients

 Takeda Pharmaceuticals U.S.A., Inc. ("Takeda") has announced moves which will strengthen the focus on its recent product launches in...


Feb 03, 2016, 20:36 ET FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder (MDD)

 Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the U.S. Food and Drug Administration's...


Jan 27, 2016, 12:00 ET FDA Approves Takeda's Dexilant SoluTab (dexlansoprazole)

 Takeda Pharmaceuticals U.S.A., Inc., (Takeda) (TSE: 4502) today announced that the United States (U.S.) Food and Drug Administration (FDA)...


Nov 13, 2015, 10:18 ET Takeda Receives Back-to-Back Recognition, Named a 2015 Top Chicago Workplace

 Takeda announced today that the Chicago Tribune named Takeda's Deerfield campus among Chicago's Top 100 Workplaces in 2015. This is the fourth...


Oct 19, 2015, 13:44 ET Takeda Presents Vedolizumab Data at the 2015 American College of Gastroenterology (ACG) Annual Meeting

Takeda Pharmaceuticals, U.S.A., Inc. ("Takeda"), today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of...


Oct 12, 2015, 07:30 ET Actress Sara Rue Urges Women to Resolve Now Rather Than Wait until the New Year to Start a Weight Loss Program

 In the United States, approximately 66 percent of women aged 20 and older are estimated as overweight or obese (BMI ≥ 25 kg/m2).1...


Oct 02, 2015, 10:57 ET Takeda Celebrates Fifth Annual Takeda Cares Day by Expanding Nationwide and Raising More Than $250,000 for Chicagoland Nonprofits

 For the fifth consecutive year, Takeda Pharmaceutical employees are gathering at the company's U.S. headquarters in Deerfield to raise money...


Sep 11, 2015, 18:59 ET More than 96 Percent of Claimants Opt-In to ACTOS Resolution Program; Takeda Expects Resolution to Become Effective Once Submission Review Completed; Takeda Stands Behind ACTOS

 Takeda Pharmaceutical Company Limited (TSE: 4502) and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. (collectively...


Aug 10, 2015, 18:36 ET FDA Accepts a Supplemental New Drug Application for Review of Brintellix® (vortioxetine) Clinical Trial Data That Assessed Cognitive Function in Patients with Major Depressive Disorder

Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) announced today the U.S. Food and Drug Administration (FDA) has...


Jul 30, 2015, 10:21 ET Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA

Takeda Pharmaceutical Company Limited ("Takeda") today announced the completion of the study to fulfill the post-marketing commitment and...


Jul 30, 2015, 02:00 ET Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1%

Guidance for FY2015 confirmed, including Core Earnings and Core EPS   Highlights of Q1 results ...


Jul 27, 2015, 06:00 ET DNDi and Takeda Collaborate for the Lead Optimization for Aminopyrazole Series for Visceral Leishmaniasis

Drugs for Neglected Diseases initiative (Headquarters: Geneva, Switzerland; Executive Director: Bernard Pécoul, Doctor; "DNDi") and Takeda...


Jun 05, 2015, 17:15 ET Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Takeda Pharmaceutical Company Limited, ("Takeda") today announced additional post-hoc analyses from the global EXAMINE (EXamination of...


May 18, 2015, 10:00 ET New Petition To Help Build Awareness of Major Depressive Disorder (MDD), One of the Most Common Mental Disorders in the U.S.

 A new petition was launched today to expand people's understanding of depression by asking popular dictionaries, including Oxford Dictionary...


May 15, 2015, 02:26 ET Takeda Reports Top Line Results in Line With Guidance, With Underlying Growth of +2.8% EPS Affected by One-time Charges in FY2014 Back to Profitable Growth from FY2015 Onward

Operational guidance met  - Underlying revenue +2.8% year-over-year, in line with guidance (reported revenue growing +5.1% to 1,777.8...


Apr 28, 2015, 17:37 ET Takeda Agrees to Settle ACTOS Product Liability Lawsuits and Claims; Takeda Stresses Continued Commitment to ACTOS

 Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that they have...


Apr 16, 2015, 23:11 ET CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research

 Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company Limited (Takeda) announced today that...


Apr 14, 2015, 19:00 ET FDA Advisory Committee Reviews Takeda's Alogliptin EXAMINE Cardiovascular Safety Outcomes Trial

Takeda Pharmaceuticals U.S.A. Inc. and Takeda Pharmaceutical Company Limited, ("Takeda") today announced that members of the Endocrinologic and...


Apr 13, 2015, 08:40 ET Takeda Announces Appointment of New President of U.S. Business Unit

 Takeda Pharmaceutical Company Limited ("Takeda"), and Takeda's wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. ("TPUSA")...